✨ 7 results found - Searched 22058 records in 5ms.
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
Tesis
Analisis terapi afatinib pada adenokarsinoma paru dengan mutasi epidermal growth factor receptor (EGFR) di RSUP Persahabatan
2023 | BY Widya Angasreni - Sita Laksmi Andarini - Jamal Zaini- Therapy Analysis of afatinib in lung adenocarcinoma with epidermal growth factor receptor mutation (EGFR) at Persahabatan Hospital.
- Nomor Panggil T23185fk
Tesis
Profil dan Angka Tahan Hidup 1 tahun Kanker Paru Bukan Sel Kecil (KPKBSK) Jenis Adenokarsinoma Paru dengan Mutasi Epidermal Growth Factor Receptor (EGFR) Exon 20 T790M Primer di RSUP Persahabatan
2018 | BY Hapsari Retno Dewanti - Sita Laksmi Andarini - Jamal Zaini- The Characteristics and One Year Survival of Lung Adenocarcinoma Patients with Primary Exon 20 T790M Epidermal Growth Factor Receptor Mutation Treated at Persahabatan Hospital Jakarta, Indonesia.
- Nomor Panggil T18468fk
Tesis
Angka tahan hidup pasien kangker paru kelompok bukan sel kecil non skuamosa yang mendapat terapi target Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor dan yang mendapat Kemoterapi lini pertama di Rumah sakit Persahabatan
2014 | BY Sita Laksmi Andarini - Kasum Supriadi - Achmad Hudoyo- The survival rate of nonsquamous by non small cell lung carcinoma patiens who are given by target therapy epidermal growth facttor receptor-tyrosin kinase inhibitors and those given by first-line kemotheraphy treatment at Persahabatan hospital.
- Nomor Panggil T14579fk
Tesis
Profil Efikasi dan Toksisitas Terapi Target Baru Golongan Epidermal Factor Receptor-Tyrosine Kinase Inhibitor (EGFRTKi)Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil Non Skuamosa Dengan Mutasi EGFR Positif Dibandingkan Dengan Kemoradioterapi Pada EGFR Wild Type
2014 | BY Sita Laksmi Andarini - Wiendo Syah Putra Yahya - Achmad Hudoyo - Ahmad Utomo- Profile of Efficacy and Toxicity The New Targeted Therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in Non Small Cell Lung Cancer Non-Squamous With Mutated EGFR Compared With Chemoradiotherapy In Wild Type
- Nomor Panggil T14533fk
Tesis
Profil Mutasi Epidermal Growth Factor Receptor dan Angka Tahan Hidup Pasien Adenokarsinoma Paru Usia Muda
2016 | BY Sita Laksmi Andarini - Mia Elhidsi - Achmad Hudoyo- Profile of Epidermal Growth Factor Receptor Mutation and Survival in Young Patients with Lung Adenocarcinoma .
- Nomor Panggil T16330FK
Tesis
Peran quiescent lung cancer stem cell (CSC) dalam proses resistans terhadap agen epidermal growth factor receptortyrosine kinase inhibitor (EGFR-TKI) pada adenokarsinoma paru dengan mutasi EGFR positif
2020 | BY Moulid Hidayat - Sita Laksmi Andarini - Fumiyuki Takahashi- Role of quiescent lung cancer stem cells in epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR- TKI) resistance in EGFR-mutant lung adenocarcinoma.
- Nomor Panggil T20481fk